ROST
66
-2
CMI
58
-2
M
50
-3
PWR
67
5
EQT
47
8
AMP
54
2
MAT
43
2
VRSK
63
-3
PRU
47
-4
ISRG
71
3
SYK
55
-4
HAS
37
-4
DAL
64
2
MU
42
7
LB
9
-3
MRK
25
-5
HCA
44
-2
MAR
65
2
RRC
63
8
LEG
36
5
ROST
66
-2
CMI
58
-2
M
50
-3
PWR
67
5
EQT
47
8
AMP
54
2
MAT
43
2
VRSK
63
-3
PRU
47
-4
ISRG
71
3
SYK
55
-4
HAS
37
-4
DAL
64
2
MU
42
7
LB
9
-3
MRK
25
-5
HCA
44
-2
MAR
65
2
RRC
63
8
LEG
36
5
Financhill
Back

BNY Mellon Responsible Hrzns Corp Bd ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
34

RHCB
BNY Mellon Responsible Hrzns Corp Bd ETF

Last Price:
45.81
Seasonality Move:
-0.51%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.03
Seasonality Move:
10.65%
Sell
34
BNY Mellon Responsible Hrzns Corp Bd ETF (RHCB) is a Sell

Is BNY Mellon Responsible Hrzns Corp Bd ETF a Buy, Sell or Hold?

  • The current BNY Mellon Responsible Hrzns Corp Bd ETF [RHCB] share price is $45.81. The Score for RHCB is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • RHCB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RHCB Stock Price Chart

What is BNY Mellon Responsible Hrzns Corp Bd ETF's stock price today?

  • The BNY Mellon Responsible Hrzns Corp Bd ETF share price today is $45.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHCB is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RHCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.78 - 46.32) Sell
Bollinger Bands (100): (46.06 - 47.3) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

RHCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Sell
20-day SMA: 46.01 Sell
50-day SMA: 46.41 Sell
200-day SMA: 46.08 Sell
8-day EMA: 45.83 Sell
20-day EMA: 45.97 Sell
50-day EMA: 46.29 Sell
200-day EMA: 46.15 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

BNY Mellon Responsible Hrzns Corp Bd ETF Earnings Growth & RHCB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

BNY Mellon Responsible Hrzns Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):